Cargando…
Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population
Randomized controlled trials can provide optimal clinical evidence to assess the benefits of new devices, and it is these data that often shape device usage in real-world practice. However, individual clinical trial results sometimes appear discordant for the same device, and alternative devices are...
Autores principales: | Mahr, Claudius, Thinh Pham, Duc, Mokadam, Nahush A., Silvestry, Scott C., Cowger, Jennifer, Kiernan, Michael S., D’alessandro, David A., Coglianese, Erin E., Faraz Masood, Muhammad, Kormos, Robert L., Jacoski, Mary V., Teuteberg, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400392/ https://www.ncbi.nlm.nih.gov/pubmed/30562168 http://dx.doi.org/10.1097/MAT.0000000000000931 |
Ejemplares similares
-
HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022) -
Treatment of device thrombus in the HeartWare HVAD: surgical exchange through thoracotomy
por: Ghandour, Amale, et al.
Publicado: (2021) -
The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022) -
Design Concepts and Preclinical Results of a Miniaturized HeartWare Platform: The MVAD System
por: Cheung, Anson, et al.
Publicado: (2015) -
Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014)